Glenmark Pharma has received final USFDA approval to manufacture and market Potassium Chloride extended release capsules and oral contraceptive Norethindrone Acetate and Ethinyl Estradiol tablets in the USA. The tablet Potassium chloride tablet has an estimated market size of $74.1 million for the 12 months ended November 2015. The company has also received approval for Norethindrone Acetate and Ethinyl Estradiol tablets. It is a generic version of US-based Warner Chilcott’s oral contraceptive drug ‘Leostrin21’. Currently, Glenmark Pharma’s portfolio consists of 62 ANDAs pending approvals from the US FDA and 106 products authorised for distribution in the US.
Company Profile : Glenmark Pharma Ltd
Leave a Reply